CLN8 Research in Oulu: In Search of a Therapeutic Approach for “Northern Epilepsy” 14/04/2026
A research project funded by the NCL Foundation uses a precise mouse model to investigate CLN8 disease mechanisms and test a potential therapy.
New therapeutic approaches for NCL: Systematic drug screening for childhood dementia! 19/03/2026
A research project funded by the NCL Foundation is testing around 10,000 already known compounds to determine whether they can correct disease-related changes in childhood dementia NCL. The aim of the project is to identify promising drug candidates and accelerate their progression into clinical development.
Our new webinar series has launched and highlights the current state of research on CLN3! 13/03/2026
To mark the 200th anniversary of the first description of NCL, the NCL Foundation is launching a webinar series that sheds light on the current state of research into CLN3, one of the most common forms of NCL. In this series, international experts from various disciplines present the latest scientific findings and discuss new clinical perspectives in this field of research.
In our booklet, you now have an overview of international NCL research! 05/03/2026
We are pleased to present the new digital booklet from the NCL Foundation! It features research groups from around the world working on CLN3, a form of NCL. They demonstrate how diverse NCL research is: different approaches and focuses, various methods and structures — all with the goal of better understanding childhood dementia.
NCL-Stiftung
Holstenwall 10 · 20355 Hamburg
Tel. +49 (40) 69 666 74-0
Fax +49 (40) 69 666 74-69
SPENDENKONTO
bei der Hamburger Sparkasse
IBAN: DE50 2005 0550 1059 2230 30
BIC: HASPDEHHXXX
Zur besseren Lesbarkeit wird auf dieser Website teilweise auf genderneutrale Doppelungen verzichtet.
Alle Formulierungen gelten gleichermaßen für alle Geschlechter.
